NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

Inline comments, also known as single-line Java comments, begin with two slashes, and only impact the code on the line in which they appear. The following is an example of a single-line comment in ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from AbbVie ( (ABBV)) is ...

Some Chinese companies now catapulting ahead to make generic versions of Novo Nordisk's Wegovy also provided ingredients for more than a billion makeshift doses of weight-loss drugs sold online in the ...

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Hungry for lower prices, shoppers are reaching for generic brand goods. “The quality of the food is good, and it tastes good,” says The Atlantic’s Ellen Cushing. Walk into an Aldi, Trader Joe’s, or ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The best way to teach the concept of Java user input to new software developers is to show them ...